Episode 264: November 2020 Retinal Physician Preview with Drs. Daniel Chao and Yoshihiro Yonekawa, including discussion of gene therapy for angiogenesis and pediatric retinal disease pearls

Drs. Daniel Chao and Yoshihiro Yonekawa join for a preview of the November 2020 edition of Retinal Physician (found online at http://www.retinalphysician.com). Topics discussed include gene therapy applications for angiogenesis, pediatric retinal disease pearls, how to manage corneal surface issues after intravitreal injection, and a common mimicker of choroidal melanoma.

Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Dorc, Oxurion, and Regeneron. Dr. Chao is a consultant for Genentech and receives research funding from Genentech and Bayer. Dr. Yonekawa is a consultant for Alcon and Allergan.

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.